دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
The Atlas of cardiovascular disease in Europe and a focus on frailty and cardiovascular risk
Filippo Crea
doi : 10.1093/eurheartj/ehac066
European Heart Journal, Volume 43, Issue 8, 21 February 2022, Pages 703–705
A cardiovascular risk calculator to save millions of lives
Mark Nicholls
doi : 10.1093/eurheartj/ehab471
European Heart Journal, Volume 43, Issue 8, 21 February 2022, Pages 706–707
Changing the conversation from ‘chronic disease’ to ‘chronic health’
Sophie Cassidy, Imre Hunyor, Ian Wilcox, Luigi Fontana
doi : 10.1093/eurheartj/ehab633
European Heart Journal, Volume 43, Issue 8, 21 February 2022, Pages 708–711
Viviany Taqueti, MD MPH, talks to CardioPulse about patients, publications, and blazing your own trail
Judith Ozkan
doi : 10.1093/eurheartj/ehab865
European Heart Journal, Volume 43, Issue 8, 21 February 2022, Pages 712–713
Can low-dose aspirin help the RECOVERY of patients hospitalized with COVID-19?
Giovanna Liuzzo, Carlo Patrono
doi : 10.1093/eurheartj/ehab907
European Heart Journal, Volume 43, Issue 8, 21 February 2022, Pages 714–715
European Society of Cardiology: cardiovascular disease statistics 2021
Adam Timmis, Panos Vardas, Nick Townsend, Aleksandra Torbica, Hugo Katus, Delphine De Smedt, Chris P. Gale, Aldo P. Maggioni, Steffen E. Petersen, Radu Huculeci,Dzianis Kazakiewicz, Victor de Benito Rubio, Barbara Ignatiuk, Zahra Raisi-Estabragh, Agnieszka Pawlak, Efstratios Karagiannidis, Roderick Treskes, Dan Gaita, John F. Beltrame, Alex McConnachie, Isabel Bardinet, Ian Graham, Marcus Flather, Perry Elliott, Elias A. Mossialos, Franz Weidinger, Stephan Achenbach, on behalf of the Atlas Writing Group European Society of Cardiology
doi : 10.1093/eurheartj/ehab892
European Heart Journal, Volume 43, Issue 8, 21 February 2022, Pages 716–799
This report from the European Society of Cardiology (ESC) Atlas Project updates and expands upon the widely cited 2019 report in presenting cardiovascular disease (CVD) statistics for the 57 ESC member countries.
The year in cardiovascular medicine 2021: acute cardiovascular care and ischaemic heart disease
Susanna Price, Jason Katz, Christoph C. Kaufmann, Kurt Huber
doi : 10.1093/eurheartj/ehab908
European Heart Journal, Volume 43, Issue 8, 21 February 2022, Pages 800–806
The year in cardiovascular medicine 2021: dyslipidaemia
Lale Tokgozoglu, Carl Orringer, Henry N. Ginsberg, Alberico L. Catapano
doi : 10.1093/eurheartj/ehab875
European Heart Journal, Volume 43, Issue 8, 21 February 2022, Pages 807–817
The past year was an exciting time for clinical lipidology when we learnt more about existing therapies as well as therapies targeting novel pathways discovered through genetic studies. LDL cholesterol remained the main target and a variety of drugs to lower LDL cholesterol through different mechanisms were explored. Emerging evidence on the atherogenity of triglyceride-rich lipoproteins led to renewed interest in lowering them with new treatments. Lp(a) was back in focus with evidence on causality and new targeted therapeutics which dramatically lower Lp(a) levels. We will be able to personalise lipid lowering therapy further with this enriched armamentarium once we have the results of the cardiovascular outcome studies with some of these new agents.
Frailty and cardiovascular mortality in more than 3 million US Veterans
William Shrauner, Emily M Lord, Xuan-Mai T Nguyen, Rebecca J Song, Ashley Galloway, David R Gagnon, Jane A Driver, J Michael Gaziano, Peter W F Wilson, Luc Djousse, Kelly Cho, Ariela R Orkaby
doi : 10.1093/eurheartj/ehab850
European Heart Journal, Volume 43, Issue 8, 21 February 2022, Pages 818–826
Frailty is associated with an increased risk of all-cause mortality and cardiovascular (CV) events. Limited data exist from the modern era of CV prevention on the relationship between frailty and CV mortality. We hypothesized that frailty is associated with an increased risk of CV mortality.
Frailty and increased risk of cardiovascular disease: are we at a crossroad to include frailty in cardiovascular risk assessment in older adults?
S. Goya Wannamethee
doi : 10.1093/eurheartj/ehab818
European Heart Journal, Volume 43, Issue 8, 21 February 2022, Pages 827–829
Combination lipid-lowering therapy as first-line strategy in very high-risk patients
Kausik K Ray, Laurens F Reeskamp, Ulrich Laufs, Maciej Banach, François Mach, Lale S Tokgözoğlu, Derek L Connolly, Anja J Gerrits, Erik S G Stroes, Luis Masana, John J P Kastelein
doi : 10.1093/eurheartj/ehab718
European Heart Journal, Volume 43, Issue 8, 21 February 2022, Pages 830–833
Long-term beta-blocker treatment in stable patients after myocardial infarction: a potential impact due to changes in the diagnosis of myocardial infarction?
Jan Gerrit van der Stouwe, Jasper Boeddinghaus, Christian Mueller
doi : 10.1093/eurheartj/ehab257
European Heart Journal, Volume 43, Issue 8, 21 February 2022, Pages 834–835
Temporal changes in myocardial infarction diagnostic criteria do not account for the lack of long-term beta-blocker effect on cardiovascular prognosis
Anders Holt, Paul Blanche, Patricia McGettigan, Morten Lamberts
doi : 10.1093/eurheartj/ehab260
European Heart Journal, Volume 43, Issue 8, 21 February 2022, Pages 836–838
A right-to-left atrial shunt via an iatrogenic atrial septal defect after atrial fibrillation ablation induced by a percutaneous left ventricular assist device
Shota Tamura, Kenji Shimeno*, Yukio Abe, Takahiko Naruko
doi : 10.1093/eurheartj/ehaa1027
European Heart Journal, Volume 43, Issue 8, 21 February 2022, Page 839
Uncommon intravascular lithotripsy for the treatment of subclavian steal syndrome: a case presenting with concomitant acute coronary syndrome and transient ischaemic attack
Leonardo Varotto, Antonella De Boni, Giuseppe Iannucci, Francesco Caprioglio
doi : 10.1093/eurheartj/ehaa1082
European Heart Journal, Volume 43, Issue 8, 21 February 2022, Page 840
Erratum to: European Society of Cardiology: cardiovascular disease statistics 2021
doi : 10.1093/eurheartj/ehac064
European Heart Journal, Volume 43, Issue 8, 21 February 2022, Page 799
